Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Filter
2
Filter results
Results: 1,943
New
A Study of VERVE-102 (LY4636581) in Adults With or at High Risk for Cardiovascular Disease
Radiprodil in Participants With Hepatic Impairment
for
Hepatic Impairment
Location: DeSoto TX, San Antonio TX
Sponsor: GRIN Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07457229
Phase 1, Recruiting
New
A Study of LY4167586 in Participants With Obesity or Overweight With or Without Type 2 Diabetes
for
Obesity, Overweight, Diabetes Mellitus, Type 2
Location: Dallas TX, San Antonio TX, Springfield MO, Columbus GA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 65
Code: NCT07881887
Phase 1, Recruiting
New
A Study of Single and Multiple Doses of LY5625573 in Healthy Participants, Including Japanese and Chinese Populations, and Participants With Inflammation (High C-Reactive Protein)
for
C-Reactive Protein
Location: Dallas TX
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 65
Code: NCT07867340
Phase 1, Recruiting
New
Comparing the Extent to Which Apremilast is Made Available in the Body After Administration as an Extended-release or Immediate-release Formulation
for
Psoriasis, Arthritis, Psoriatic, Oral Ulcer
Location: Dallas TX, Daytona Beach FL
Sponsor: Amgen
Sex: All
Age: 18 - 60
Code: NCT07908641
Phase 1, Recruiting
New
Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA)
for
Obesity, Overweight
Location: Dallas TX, Knoxville TN, Lexington KY, Madison WI,
Sponsor: Amgen
Sex: All
Age: 18 - 70
Code: NCT07908316
Phase 1, Recruiting
A Study of Eloralintide (LY3841136) in Female Participants With Obesity or Overweight
for
Obesity, Overweight
Location: Dallas TX, Daytona Beach FL
Sponsor: Eli Lilly and Company
Sex: Female
Age: 18 - 60
Code: NCT07808060
Phase 1, Recruiting
A Study of LY4329090 in Participants With Obesity or Overweight Who Are Otherwise Healthy
for
Obesity, Overweight
Location: Dallas TX, Daytona Beach FL
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 65
Code: NCT07808073
Phase 1, Recruiting
A Trial in Healthy Participants to Assess Drug Interaction Potential of BGB-43395
for
Healthy Adult Participants
Location: Dallas TX
Sponsor: BeOne Medicines
Sex: All
Age: 18 - 65
Code: NCT07820891
Phase 1, Recruiting
A Study of LY4355756 in Healthy Participants
for
Healthy
Location: Dallas TX
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 65
Code: NCT07765498
Phase 1, Recruiting
A Trial to Compare the Pharmacokinetics of Two Presentations of Navenibart in Healthy Participants